SEC Form 4 research
| Issuer | SUPERNUS PHARMACEUTICALS, INC. |
|---|---|
| Tickers | SUPN |
| Reporting owners | 36 |
| Officers and directors | 22 |
| Last public filing | 2026-11-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-10-30 | Khattar Jack A. | A | 400,000 | $0 | Not reported |
| 2026-11-02 | 2026-10-30 | Rubin Jonathan | A | 70,000 | $0 | Not reported |
| 2026-11-02 | 2026-10-30 | DEC TIMOTHY C | A | 70,000 | $0 | Not reported |
| 2026-11-02 | 2026-10-30 | Mottola Frank | A | 100,000 | $0 | Not reported |
| 2026-11-02 | 2026-10-30 | Horich William Todd | A | 100,000 | $0 | Not reported |
| 2026-11-02 | 2026-10-30 | Bhatt Padmanabh P. | A | 100,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.